Dr Rebecca Kristeleit BSc, MBChB, MRCP, PhD is Clinical Senior Lecturer and Consultant Medical Oncologist at UCL/UCLH.
She specialises in the treatment of gynaecological cancers:
She also has a specialist interest in drug development as well and is leading several clinical trials of novel agents relevant to gynecological malignancies including PARP inhibitors.
Rebecca qualified in medicine from St Andrew’s and Manchester Universities including eight months at the University of Lausanne (Switzerland) on an Erasmus scholarship. Following general medical training in London, Rebecca undertook her medical oncology training at The Royal Marsden Hospital and a CRUK-funded research fellowship at the Institute of Cancer Research. Subsequently, Rebecca spent a year as a senior research fellow on the Drug Development Unit at the Royal Marsden Hospital gaining specialist experience in the design and conduct of early phase clinical trials and translational medicine.
Her research work, as part of the UCLH gynecological oncology team, Clinical Research Facility at UCLH and the UCL Cancer Institute, is focused on the development of early phase clinical trials and translational research to identify and evaluate innovative treatment strategies for gynaecological malignancies as well as other solid tumours.
Current NHS Posts
- Clinical Senior Lecturer and Consultant Medical Oncologist at UCL/UCLH.
Clinic Locations
HCA London Bridge Hospital,
London
HCA Harley Street clinic at UCLH
Wellington Hospital (Platinum Medical Centre)
Contact Details
To arrange an appointment to see Dr Rebecca Kristeleit please contact: Independent Oncology on
rebeccakristeleit@independentoncology.org.uk
Fee Schedule
To Download the fee schedule please use the link below:PDF Download
